Coya Therapeutics, Inc. Announces Preclinical Data Supporting the Role of Expanded Regulatory T Cells (Tregs) as Potential Disease-Modifying Treatment in an Animal Model of Alzheimer’s Disease (AD) - Allele Capital

https://ir.coyatherapeutics.com/news/news-details/2023/Coya-Therapeutics-Inc.-Announces-Preclinical-Data-Supporting-the-Role-of-Expanded-Regulatory-T-Cells-Tregs-as-Potential-Disease-Modifying-Treatment-in-an-Animal-Model-of-Alzheimers-Disease-AD/default.aspx